Cargando…
Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.
Mechanisms of anthracycline resistance have been investigated in a B16 murine melanoma cell subline selected by continuous in vitro exposure to increasing concentrations of doxorubicin (DX). Altered drug pharmacokinetics were observed in resistant B16 cells as compared to the sensitive counterpart....
Autores principales: | Supino, R., Mariani, M., Capranico, G., Colombo, A., Parmiani, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246448/ https://www.ncbi.nlm.nih.gov/pubmed/3358904 |
Ejemplares similares
-
In vivo characterization of a doxorubicin resistant B16 melanoma cell line.
por: Formelli, F., et al.
Publicado: (1986) -
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.
por: Supino, R., et al.
Publicado: (1986) -
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines.
por: Capranico, G., et al.
Publicado: (1989) -
Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988) -
Molecular and Cellular Functions of the Warsaw Breakage Syndrome DNA Helicase DDX11
por: Pisani, Francesca M., et al.
Publicado: (2018)